By Colin Kellaher
Enovis has hired Damien McDonald to succeed Matt Trerotola as chief executive of the medical-technology company.
Enovis on Wednesday said McDonald, who most recently served as CEO of medical-device company LivaNova, takes the helm of the Wilimington, Del., company on May 12 and will also join the board.
Enovis in February said Trerotola, who has been CEO since 2015, was planning to retire.
The company on Wednesday said Trerotola, who is currently chairman, won't stand for re-election to the board at the annual shareholder meeting on May 21 and that Sharon Wienbar, who has served as lead independent director since May 2023, will become independent board chair.
Enovis said McDonald, 60 years old, will receive an annual base salary of $1 million and an annual bonus with a target of 125% of his base pay.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
April 02, 2025 06:52 ET (10:52 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。